U.S. federal trademark · Serial No. 88573422
Pharmaceutical research and development services; Medical and scientific research information in the field of novel pharmaceutical discovery and development; Research and development in the pharmaceutical and biotechnology fields; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials; Medical and scientific research, namely, conducting clinical trials for others of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of New Therapeutic Entities (NTEs) defined as pharmacological treatments based on molecules that are already approved for other indications that are neither New Chemical Entities (NCEs) nor generics and New Chemical Entities (NCEs) and Biologic License Application (BLAs) as novel pharmaceutical treatments; Research and development in the field of novel pharmaceutical treatments and clinical trials; Providing medical and scientific research information in the field of novel pharmaceutical treatments and clinical trials; Clinical trials services for others
Pharmaceutical and biological preparations for the treatment of anorectal diseases and gastrointestinal and liver disorders; Targeted pharmacological and biological treatments for anorectal diseases, liver, and gastrointestinal disorders such as fecal incontinence, pruritus ani, and radiation proctitis; Prescription and non-prescription pharmacological and biological treatments administered in various pharmaceutical technological forms namely, in solid form pills, tablets, capsules, caplets, sachets, in semi-liquid form namely, gels, ointments and pastes, suppositories, in liquid form namely, drops, injectables, infusions, in gaseous form namely, inhalants, or in sprays, namely, intranasally administered medications, for the treatment of anorectal diseases and gastrointestinal illnesses and disorders; Capsules sold empty for pharmaceuticals; Drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals; Suppositories with proprietary delivery system for the precise delivery of drugs that target conditions and diseases of the anorectal region; Suppositories
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.